Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Influenza vaccine coverage, effectiveness, and disease burden among pediatric sickle cell patients in Connecticut from 2021-2024: A test-negative case-control study

Precious Nchekwube, Hillary Kuzaro, Elizabeth Cohen, Cecelia Calhoun, Lakshmanan Krishnamurti, Farzana Pashankar, Nitya Bakshi, Inci Yildirim

Blood (2025) 146 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2025-4745

Published: 2025

Journal Articles

Burnout in sickle cell disease-focused hematology-oncology trained providers: A national cross-sectional study

Valentina Restrepo, Jennifer Afranie-Sakyi, Bria Carrithers, Boubini Jones-Wonni, Ronak Mistry, Cheryl Mensah, Patrick McGann, Sharl Azar, Laura De Castro, Cecelia Calhoun, Ariela Marshall, Alfred Lee, Layla Van Doren

Blood (2025) 146 (Supplement 1): 831.

https://doi.org/10.1182/blood-2025-831

Published: 2025

Journal Articles

Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype

Lauren Merz, Gilles Attipoe, Christina Barriteau, Michael Blechner, Eric Burks, Cecelia Calhoun, Sally Campbell Lee, Vivian Chang, Stella Chou, Adam Cuker, Emmanuel Fadeyi, Warren Fingrut, Victoria Forbes, Ivo Francischetti, Vijayakrishna Gadi, Richard Godby, Lucy Godley, Abraham Haimed, Hyojeong Han, Richard Haspel, Chibuzo Ilonze, Cyril Jacquot, Peng Ji, Justin Juskewitch, Matthew Karafin, Kimberly Klein, Nicole Kucine, Priya Kumar, Margarita Kushnir, David Levitz, Michael Lewis, Geling Li, Zhen Mei, Sabrina Racine Brzostek, Gary Rose, Corinna Schultz, Alexa Siddon, Christine Sillings, John Mark Sloan, Amy Soni, Don Stevens, Charlotte Story, James Szymanski, Clifford Takemoto, Alexis Thompson, Rahma Warsame, Angela Weyand, Samuel Wilson, Nibal Zaghloul, Yadashe Belay, Aliza Fink, Patricia Frustace, Jamie Tyson, Nathalie Van Havre, Maureen Okam Achebe

Blood (2025) 146 (Supplement 1): 1074.

https://doi.org/10.1182/blood-2025-1074

Published: 2025

Journal Articles

Impact of a near-peer group mentorship program on improving transition skills for adolescents and young adults living with sickle cell disease

Midori Hosoda, Kepler Jeudy, Kimberly Vasquez, Carson Ferrara, Cecelia Calhoun

Blood (2025) 146 (Supplement 1): 4437.

https://doi.org/10.1182/blood-2025-4437

Published: 2025

Journal Articles

Innate immune dysregulation in monocytes in sickle cell disease

Sarah Hinderstein, Gemma Vidal-Pedrola, Subhasis Mohanty, Irene Matos, Fanny Alarcon, Judith Carbonella, Cecelia Calhoun, Lakshmanan Krishnamurti, Albert Shaw, Inci Yildirim

Blood (2025) 146 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2025-1155

Published: 2025

Journal Articles

Buprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles

Jennifer A. Afranie-Sakyi, Max Jordan Nguemeni Tiako, Kimberly S. Vasquez, Layla N Van Doren, Cecelia Calhoun

Blood (2024) 144 (Supplement 1): 3628.

https://doi.org/10.1182/blood-2024-194039

Published: 2024

Journal Articles

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Karthik Chetlapalli, Ayesha Butt, Satoko Ito, Daniel Wang, Cecelia Calhoun, Lakshmanan Krishnamurti, Ankur Pandya, George Goshua

Blood (2024) 144 (Supplement 1): 601.

https://doi.org/10.1182/blood-2024-203234

Published: 2024

Journal Articles

Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing?

Jennifer A. Afranie-Sakyi, Modupe Karimi, Janis Bozzo, Joanna Cole, Layla N Van Doren, Cecelia Calhoun

Blood (2024) 144 (Supplement 1): 5009.

https://doi.org/10.1182/blood-2024-201816

Published: 2024

Journal Articles

Screening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing?

Jennifer A. Afranie-Sakyi, Modupe Karimi, Janis Bozzo, Joanna Cole, Layla N Van Doren, Cecelia Calhoun

Blood (2024) 144 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2024-211906

Published: 2024

Journal Articles

Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers

Max Jordan Nguemeni Tiako, Jennifer A. Afranie-Sakyi, Layla N Van Doren, Kimberly S. Vasquez, Cecelia Calhoun

Blood (2024) 144 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2024-206368

Published: 2024

Journal Articles

Trainees' Perspectives on Components of Sickle Cell Specific Education

Layla N Van Doren, Katherine J Feder, Cecelia Calhoun, C. Patrick Carroll, Elizabeth Prince

Blood (2023) 142 (Supplement 1): 791.

https://doi.org/10.1182/blood-2023-180303

Published: 2023

Journal Articles

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

George Goshua, Satoko Ito, Karthik Chetlapalli, Kunal C Potnis, Cecelia Calhoun, Lakshmanan Krishnamurti, Harlan M. Krumholz, Ankur Pandya

Blood (2023) 142 (Supplement 1): 490.

https://doi.org/10.1182/blood-2023-191072

Published: 2023

Journal Articles

Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department

Jodi Forward, Donna-Ann Thomas, Shannon O'Malley, Adam Berkwitt, Cecelia Calhoun, Lakshmanan Krishnamurti, Farzana D. Pashankar

Blood (2023) 142 (Supplement 1): 2315.

https://doi.org/10.1182/blood-2023-181285

Published: 2023

Journal Articles

Perspectives of Adolescents and Young Adults with Sickle Cell Disease and Clinicians on Improving Transition Readiness and a Videogame Intervention

Paul L. Aronson, Sarah A. Nolan, Paula Schaeffer, Kimberly Hieftje, Kortney A. Ponce, Cecelia Calhoun

Blood (2023) 142 (Supplement 1): 5116.

https://doi.org/10.1182/blood-2023-173310

Published: 2023

Journal Articles

Gene Therapy Equity in Sickle Cell Disease: Distributional Cost-Effectiveness Analysis (DCEA) of Gene Therapy Vs. Standard-of-Care in Patients with Sickle Cell Disease in the United States

George Goshua, Cecelia Calhoun, Vivien Cheng, Lyndon James, Andrea Luviano, Lakshmanan Krishnamurti, Ankur Pandya

Blood (2022) 140 (Supplement 1): 1395–1396.

https://doi.org/10.1182/blood-2022-157460

Published: 2022

Journal Articles

Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-141471

Published: 2020

Journal Articles

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Kelly M Harris, PhD, Taniya Varughese, MSOT, OTR/L, Anna Bauer, BA, Seth Howdeshell, MD, Cecelia Calhoun, MD, Regina Abel, PhD, Allison A. King, MD MPH, PhD

Blood (2019) 134 (Supplement_1): 419.

https://doi.org/10.1182/blood-2019-129874

Published: 2019

Journal Articles

Evaluation of Factors Influencing Health Literacy in Adolescents and Adults with Sickle Cell Disease

Nidhi Bhatt, MD, Cecelia Calhoun, MD, Jason R. Hodges, PhD MA, Chinonyelum Nwosu, Guolian Kang, PhD, Allison A. King, MD MPH, PhD, Xiwen Zhao, MSPH, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 2110.

https://doi.org/10.1182/blood-2019-130755

Published: 2019

Journal Articles

Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease

Cecelia Calhoun, MD MPHS, Lingzi Luo, MSW, MPH, Ana Baumann, PhD, Aimee James, PhD, Allison King, MD MPH, PhD

Blood (2018) 132 (Supplement 1): 2274.

https://doi.org/10.1182/blood-2018-99-113150

Published: 2018

Journal Articles

Current Healthcare Utilization Patterns and Most Common Reasons for Admission Amongst Patients with Sickle Cell Disease

Cecelia Calhoun, MD MPHS, Matthew Keller, MS, Margaret Olsen, MPH, PhD, Allison King, MDMPH,PhD

Blood (2017) 130 (Supplement 1): 866.

https://doi.org/10.1182/blood.V130.Suppl_1.866.866

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Influenza vaccine coverage, effectiveness, and disease burden among pediatric sickle cell patients in Connecticut from 2021-2024: A test-negative case-control study

Burnout in sickle cell disease-focused hematology-oncology trained providers: A national cross-sectional study

Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype

Impact of a near-peer group mentorship program on improving transition skills for adolescents and young adults living with sickle cell disease

Innate immune dysregulation in monocytes in sickle cell disease

Buprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles

Deciding between Multiple Curative Options in Sickle Cell Disease: Cost-Effectiveness of Non-Myeloablative/Reduced Intensity Conditioning Haploidentical Allo-HSCT Vs Gene Therapy Vs Standard of Care in Adult Patients with Sickle Cell Disease

Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing?

Screening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing?

Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers

Trainees' Perspectives on Components of Sickle Cell Specific Education

Allotransplantation and Gene Therapy Equity for Children with Sickle Cell Disease: Distributional Cost-Effectiveness of Allotransplantation Vs Gene Therapy Vs Standard-of-Care in Pediatric Patients with Sickle Cell Disease in the United States

Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department

Perspectives of Adolescents and Young Adults with Sickle Cell Disease and Clinicians on Improving Transition Readiness and a Videogame Intervention

Gene Therapy Equity in Sickle Cell Disease: Distributional Cost-Effectiveness Analysis (DCEA) of Gene Therapy Vs. Standard-of-Care in Patients with Sickle Cell Disease in the United States

Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Evaluation of Factors Influencing Health Literacy in Adolescents and Adults with Sickle Cell Disease

Understanding Health Knowledge Gaps to Optimize Transitions of Care for Young Adults with Sickle Cell Disease

Current Healthcare Utilization Patterns and Most Common Reasons for Admission Amongst Patients with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only